Rxsight, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

25 Feb 2026

RXST

10-K: RxSight Reports Mixed 2025 Results Amid Sales Reorganization

RxSight, Inc. reported a 3.9% decrease in total sales for 2025 to $134.5 million, driven by slower adoption of its Light Delivery Devices, despite an increase in Light Adjustable Lens sales and improved gross margin.

NASDAQ

25 Feb 2025

RXST

Rxsight, INC

10-K: RxSight, Inc. Reports Strong Growth in 2024, Expands Market Share in Premium Cataract Surgery

RxSight, Inc. announces significant revenue increase and expansion in its LDD installed base, solidifying its position in the premium IOL market.

NASDAQ

28 Feb 2024

RXST

Rxsight, INC

10-K: RxSight Reports 2023 Financial Results, Highlights Growth in Light Adjustable Lens Adoption

RxSight, Inc. reports a significant increase in revenue and installed base for its Light Adjustable Lens system in its 2023 annual filing.